Clinical Trials Directory

Trials / Completed

CompletedNCT04694001

Evaluation of the Use of the Atalante Exoskeleton in Patients Presenting an Hemiplegia Due to Cerebrovascular Accident

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Wandercraft · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The INSPIRE study is interventional, European, prospective, open, multicentric, each patient being his/her own control. It is conducted to assess the safety and performance of the Atalante exoskeleton system in patients presenting an hemiplegia due to cerebrovascular accident. The primary endpoint is defined by the reported adverse events. The study will include 40 patients and takes place in six rehabilitation centers (4 in France, 1 in Luxembourg, 1 in Belgium).

Conditions

Interventions

TypeNameDescription
DEVICEUse of the Atalante exoskeletonA session includes stand-up, walks, exercises with or without the assistance of the exoskeleton, rotation, side and back step, squat and sitting.

Timeline

Start date
2021-04-12
Primary completion
2022-03-28
Completion
2022-03-28
First posted
2021-01-05
Last updated
2022-04-27

Locations

6 sites across 3 countries: Belgium, France, Luxembourg

Source: ClinicalTrials.gov record NCT04694001. Inclusion in this directory is not an endorsement.